Bronnen:
- Hofman MS, Violet J, Hicks RJ et al. [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study. The Lancet Oncology, 8 mei 2018. https://doi.org/10.1016/S1470-2045(18)30198-0